Loading...

George Kaysen

TitlePROF EMERITUS(WOS)
InstitutionUniversity of California Davis
DepartmentNephrology
Address6300 GBSF
CA 95616
Phone530-752-4010
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Johansen KL, Delgado C, Kaysen GA, Chertow GM, Chiang J, Dalrymple LS, Segal MR, Grimes BA. Frailty among patients receiving hemodialysis: evolution of components and associations with mortality. J Gerontol A Biol Sci Med Sci. 2018 Sep 05. PMID: 30192916.
      View in: PubMed
    2. Chiang JM, Kaysen GA, Segal M, Chertow GM, Delgado C, Johansen KL. Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis. Nephrol Dial Transplant. 2018 Aug 01. PMID: 30085235.
      View in: PubMed
    3. Kaysen G, Ye X, Raimann JG, Wang Y, Topping A, Usvyat LA, Stuard S, Canaud B, Sande FMV, Kooman JP, Kotanko P. Lipid levels are inversely associated with infectious and all-cause mortality: International MONDO study results. J Lipid Res. 2018 Jun 12. PMID: 29895699.
      View in: PubMed
    4. Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials. Am J Nephrol. 2018; 47(3):208-217. PMID: 29621747.
      View in: PubMed
    5. Chiang JM, Kaysen GA, Schafer AL, Delgado C, Johansen KL. Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue. J Ren Nutr. 2018 Mar 29. PMID: 29606304.
      View in: PubMed
    6. Madan N, Kaysen GA. Gut Endothelial Leakage of Endotoxin May Be the Source of Vascular Inflammation and Injury in CKD. How Can This Be Targeted? J Ren Nutr. 2018 Jan; 28(1):1-3. PMID: 29249294.
      View in: PubMed
    7. Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T, Johansen KL. Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. J Clin Lipidol. 2018 Mar - Apr; 12(2):481-487.e14. PMID: 29361496.
      View in: PubMed
    8. Molfino A, Beck GJ, Li M, Lo JC, Kaysen GA. The Association Between Change in Serum Bicarbonate and Change in Thyroid Hormone Levels in Patients Receiving Conventional or More Frequent Maintenance Hemodialysis. Nephrology (Carlton). 2017 Oct 24. PMID: 29064128.
      View in: PubMed
    9. Delgado C, Chertow GM, Kaysen GA, Dalrymple LS, Kornak J, Grimes B, Johansen KL. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis. Am J Kidney Dis. 2017 Dec; 70(6):817-825. PMID: 28870376.
      View in: PubMed
    10. Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, Grimes B, Kaysen GA. Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1100-1108. PMID: 28576906.
      View in: PubMed
    11. Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017 07; 92(1):238-247. PMID: 28318630.
      View in: PubMed
    12. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541. PMID: 28301073.
      View in: PubMed
    13. Krishnan S, Shimoda M, Sacchi R, Kailemia MJ, Luxardi G, Kaysen GA, Parikh AN, Ngassam VN, Johansen K, Chertow GM, Grimes B, Smilowitz JT, Maverakis E, Lebrilla CB, Zivkovic AM. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. Sci Rep. 2017 Mar 13; 7:43728. PMID: 28287093.
      View in: PubMed
    14. Kaysen GA. Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients. Blood Purif. 2017; 43(1-3):196-199. PMID: 28114129.
      View in: PubMed
    15. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 04; 21(2):190-196. PMID: 27774730.
      View in: PubMed
    16. Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017 Feb; 8(1):57-68. PMID: 27897415.
      View in: PubMed
    17. Ananthakrishnan S, Kaysen GA. Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale. Adv Chronic Kidney Dis. 2016 07; 23(4):247-54. PMID: 27324678.
      View in: PubMed
    18. Abreo AP, Dalrymple LS, Chertow GM, Kaysen GA, Herzog CA, Johansen KL. Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis. Hemodial Int. 2017 Jan; 21(1):133-141. PMID: 27346666.
      View in: PubMed
    19. Kutner NG, Zhang R, Huang Y, Kaysen GA, Park J. Lower C-reactive protein and better hemodialysis survival are associated with regular exercise activity: Longitudinal outcomes from the ACTIVE-ADIPOSE special study. Hemodial Int. 2016 07; 20(3):473-83. PMID: 26954723.
      View in: PubMed
    20. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif. 2016; 41(4):277-86. PMID: 26795100.
      View in: PubMed
    21. Johansen KL, Dalrymple LS, Glidden D, Delgado C, Kaysen GA, Grimes B, Chertow GM. Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):626-32. PMID: 26792529; PMCID: PMC4822658 [Available on 04/07/17].
    22. Kittiskulnam P, Chertow GM, Kaysen GA, Delgado C, Dalrymple LS, Johansen KL. Misclassification of Obesity by Body Mass Index Among Patients Receiving Hemodialysis. Am J Kidney Dis. 2016 Apr; 67(4):709-11. PMID: 26612278.
      View in: PubMed
    23. Dalrymple LS, Mu Y, Nguyen DV, Romano PS, Chertow GM, Grimes B, Kaysen GA, Johansen KL. Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis. Clin J Am Soc Nephrol. 2015 Dec 07; 10(12):2170-80. PMID: 26567370; PMCID: PMC4670763 [Available on 12/07/16].
    24. Molfino A, Kaysen GA, Chertow GM, Doyle J, Delgado C, Dwyer T, Laviano A, Rossi Fanelli F, Johansen KL. Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis. J Ren Nutr. 2016 Mar; 26(2):103-10. PMID: 26522141.
      View in: PubMed
    25. Delgado C, Shieh S, Grimes B, Chertow GM, Dalrymple LS, Kaysen GA, Kornak J, Johansen KL. Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis. Am J Nephrol. 2015; 42(2):134-40. PMID: 26381744; PMCID: PMC4596065.
    26. Abreo AP, Chertow GM, Dalrymple LS, Kaysen GA, Johansen KL. Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis. Hemodial Int. 2015 Oct; 19(4):536-42. PMID: 25881673; PMCID: PMC4778547 [Available on 10/01/16].
    27. Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J Ren Nutr. 2015 Jul; 25(4):351-6. PMID: 25802017.
      View in: PubMed
    28. Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, Grimes B, Kaysen GA, Johansen KL. Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis. Am J Kidney Dis. 2015 May; 65(5):754-62. PMID: 25641061; PMCID: PMC4414702.
    29. Raimann JG, Abbas SR, Liu L, Zhu F, Larive B, Kotanko P, Levin NW, Kaysen GA. Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the Frequent Hemodialysis Network Daily Trial. Nephron Clin Pract. 2014; 128(1-2):115-26. PMID: 25402657; PMCID: PMC4420240.
    30. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int. 2015 Jan; 87(1):169-75. PMID: 25029429.
      View in: PubMed
    31. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014 Oct; 64(4):600-7. PMID: 24793033; PMCID: PMC4177262.
    32. Abbas SR, Zhu F, Kaysen GA, Kotanko P, Levin NW. Effect of change in fluid distribution in segments in hemodialysis patients at different ultrafiltration rates on accuracy of whole body bioimpedance measurement. J Appl Physiol (1985). 2014 Jun 01; 116(11):1382-9. PMID: 24674858.
      View in: PubMed
    33. Delgado C, Ward P, Chertow GM, Storer L, Dalrymple L, Block T, Kaysen GA, Kornak J, Grimes B, Kutner NG, Johansen KL. Calibration of the brief food frequency questionnaire among patients on dialysis. J Ren Nutr. 2014 May; 24(3):151-156.e1. PMID: 24613023.
      View in: PubMed
    34. Kaysen GA. Progressive inflammation and wasting in patients with ESRD. Clin J Am Soc Nephrol. 2014 Feb; 9(2):225-6. PMID: 24458072; PMCID: PMC3913250.
    35. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014 Jan; 9(1):73-81. PMID: 24370770; PMCID: PMC3878699.
    36. Kaysen GA, Chin A. If oxidative stress is an appropriate and specific target, what reagent should we choose? J Am Soc Nephrol. 2014 Mar; 25(3):427-9. PMID: 24357667; PMCID: PMC3935597.
    37. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol. 2014 Feb; 25(2):381-9. PMID: 24158987; PMCID: PMC3904567.
    38. Raimann JG, Zhu F, Wang J, Thijssen S, Kuhlmann MK, Kotanko P, Levin NW, Kaysen GA. Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods. Kidney Int. 2014 Apr; 85(4):898-908. PMID: 24067432.
      View in: PubMed
    39. Kaysen GA, Dalrymple LS, Grimes B, Chertow GM, Kornak J, Johansen KL. Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):430-7. PMID: 24009290.
      View in: PubMed
    40. Anand S, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kaysen GA, Kurella Tamura M. Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study. J Ren Nutr. 2013 Nov; 23(6):422-7. PMID: 23876600.
      View in: PubMed
    41. Molfino A, Don BR, Kaysen GA. Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients. Nephron Clin Pract. 2012; 122(3-4):127-33. PMID: 23689544; PMCID: PMC4353643.
    42. Molfino A, Heymsfield SB, Zhu F, Kotanko P, Levin NW, Dwyer T, Kaysen GA. Prealbumin is associated with visceral fat mass in patients receiving hemodialysis. J Ren Nutr. 2013 Nov; 23(6):406-10. PMID: 23623396; PMCID: PMC4209593.
    43. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY, ter Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar; 23(2):77-90. PMID: 23428357.
      View in: PubMed
    44. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013 May; 83(5):949-58. PMID: 23344474; PMCID: PMC3855839.
    45. Kaysen GA, Odabaei G. Dietary protein restriction and preservation of kidney function in chronic kidney disease. Blood Purif. 2013; 35(1-3):22-5. PMID: 23343542.
      View in: PubMed
    46. Sentürk D, Dalrymple LS, Mohammed SM, Kaysen GA, Nguyen DV. Modeling time-varying effects with generalized and unsynchronized longitudinal data. Stat Med. 2013 Jul 30; 32(17):2971-87. PMID: 23335196; PMCID: PMC3702655.
    47. Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, Chertow GM. Association of physical activity with survival among ambulatory patients on dialysis: the Comprehensive Dialysis Study. Clin J Am Soc Nephrol. 2013 Feb; 8(2):248-53. PMID: 23124787; PMCID: PMC3562868.
    48. Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med. 2012 Jul 23; 172(14):1071-7. PMID: 22733312; PMCID: PMC4117243.
    49. Anand S, Johansen KL, Grimes B, Kaysen GA, Dalrymple LS, Kutner NG, Chertow GM. Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study. Hemodial Int. 2013 Jan; 17(1):50-8. PMID: 22812496.
      View in: PubMed
    50. Wang L, Shearer GC, Budamagunta MS, Voss JC, Molfino A, Kaysen GA. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. Kidney Int. 2012 Nov; 82(9):990-9. PMID: 22785171.
      View in: PubMed
    51. Dalrymple LS, Johansen KL, Chertow GM, Grimes B, Anand S, McCulloch CE, Kaysen GA. Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study. J Ren Nutr. 2013 Mar; 23(2):91-7. PMID: 22633987; PMCID: PMC3434280.
    52. Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int. 2012 Jul; 82(1):90-9. PMID: 22456602; PMCID: PMC3328304.
    53. Dalrymple LS, Kaysen GA. Obesity and mortality on dialysis--does age matter? Nat Rev Nephrol. 2012 Mar 27; 8(5):258-60. PMID: 22450439.
      View in: PubMed
    54. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012 May; 7(5):782-94. PMID: 22422538; PMCID: PMC3338281.
    55. Dalrymple LS, Mohammed SM, Mu Y, Johansen KL, Chertow GM, Grimes B, Kaysen GA, Nguyen DV. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1708-13. PMID: 21566109.
      View in: PubMed
    56. Anand S, Kaysen GA, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kurella Tamura M. Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant. 2011 Nov; 26(11):3683-8. PMID: 21430182.
      View in: PubMed
    57. Sriram R, Lagerstedt JO, Petrlova J, Samardzic H, Kreutzer U, Xie H, Kaysen GA, Desreux JF, Thonon D, Jacques V, Van Loan M, Rutledge JC, Oda MN, Voss JC, Jue T. Imaging apolipoprotein AI in vivo. NMR Biomed. 2011 Aug; 24(7):916-24. PMID: 21264979; PMCID: PMC3726305.
    58. Anand S, Chertow GM, Johansen KL, Grimes B, Kurella Tamura M, Dalrymple LS, Kaysen GA. Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study. J Ren Nutr. 2011 Nov; 21(6):429-37. PMID: 21239185.
      View in: PubMed
    59. Kaysen GA. New insights into lipid metabolism in chronic kidney disease. J Ren Nutr. 2011 Jan; 21(1):120-3. PMID: 21195934.
      View in: PubMed
    60. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011 Jan; 57(1):101-12. PMID: 21184919; PMCID: PMC3073398.
    61. Johansen KL, Chertow GM, Kutner NG, Dalrymple LS, Grimes BA, Kaysen GA. Low level of self-reported physical activity in ambulatory patients new to dialysis. Kidney Int. 2010 Dec; 78(11):1164-70. PMID: 20811334; PMCID: PMC4170106.
    62. Bakris G, Vassalotti J, Ritz E, Wanner C, Stergiou G, Molitch M, Nesto R, Kaysen GA, Sowers JR. National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events. Kidney Int. 2010 Oct; 78(8):726-36. PMID: 20720529.
      View in: PubMed
    63. Dalrymple LS, Johansen KL, Chertow GM, Cheng SC, Grimes B, Gold EB, Kaysen GA. Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis. 2010 Sep; 56(3):522-30. PMID: 20619518; PMCID: PMC2926212.
    64. Kaysen GA. Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S56-63. PMID: 19996007.
      View in: PubMed
    65. Kaysen GA. Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease. Kidney Int. 2009 Aug; 76(4):359-61. PMID: 19644477.
      View in: PubMed
    66. Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, Dwyer T, Usvyat L, Havel P, Levin NW. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr. 2009 Sep; 19(5):357-64. PMID: 19596588; PMCID: PMC3038251.
    67. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009 Jun; 20(6):1199-209. PMID: 19470680.
      View in: PubMed
    68. Kutner NG, Johansen KL, Kaysen GA, Pederson S, Chen SC, Agodoa LY, Eggers PW, Chertow GM. The comprehensive dialysis study (CDS): a USRDS special study. Clin J Am Soc Nephrol. 2009 Mar; 4(3):645-50. PMID: 19261814; PMCID: PMC2653653.
    69. Kaysen GA. New insights into lipid metabolism in chronic kidney disease: what are the practical implications? Blood Purif. 2009; 27(1):86-91. PMID: 19169024.
      View in: PubMed
    70. Kaysen GA. Lipid and lipoprotein metabolism in chronic kidney disease. J Ren Nutr. 2009 Jan; 19(1):73-7. PMID: 19121776.
      View in: PubMed
    71. Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, Levin NW. Estimation of adipose pools in hemodialysis patients from anthropometric measures. J Ren Nutr. 2008 Nov; 18(6):473-8. PMID: 18940649.
      View in: PubMed
    72. Kaysen GA, Johansen KL, Cheng SC, Jin C, Chertow GM. Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. J Ren Nutr. 2008 Jul; 18(4):323-31. PMID: 18558296.
      View in: PubMed
    73. Dalrymple LS, Kaysen GA. The effect of lipoproteins on the development and progression of renal disease. Am J Nephrol. 2008; 28(5):723-31. PMID: 18434711.
      View in: PubMed
    74. Hsu J, Johansen KL, Hsu CY, Kaysen GA, Chertow GM. Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol. 2008 Jul; 3(4):992-7. PMID: 18417750; PMCID: PMC2440282.
    75. Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs. 2007 Nov; 30(11):987-92. PMID: 18067100.
      View in: PubMed
    76. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial. 2007 Nov-Dec; 20(6):586-92. PMID: 17991209.
      View in: PubMed
    77. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80. PMID: 17971309; PMCID: PMC4265765.
    78. Kaysen GA. Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance. Kidney Int. 2007 Oct; 72(7):779-81. PMID: 17882238.
      View in: PubMed
    79. Lo JC, Go AS, Chandra M, Fan D, Kaysen GA. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8. PMID: 17900454.
      View in: PubMed
    80. Newman JW, Kaysen GA, Hammock BD, Shearer GC. Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat. J Lipid Res. 2007 Aug; 48(8):1792-800. PMID: 17496268.
      View in: PubMed
    81. Kaysen GA. Disorders in high-density metabolism with insulin resistance and chronic kidney disease. J Ren Nutr. 2007 Jan; 17(1):4-8. PMID: 17198924.
      View in: PubMed
    82. Kaysen GA, Levin NW, Mitch WE, Chapman AL, Kubala L, Eiserich JP. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients. Blood Purif. 2006; 24(5-6):508-16. PMID: 17077623.
      View in: PubMed
    83. Kaysen GA. Metabolic syndrome and renal failure: similarities and differences. Panminerva Med. 2006 Sep; 48(3):151-64. PMID: 17122751.
      View in: PubMed
    84. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis. 2006 Jan; 47(1):131-8. PMID: 16377394.
      View in: PubMed
    85. Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif. 2006; 24(1):51-5. PMID: 16361841.
      View in: PubMed
    86. Kaysen GA, Müller HG, Ding J, Chertow GM. Challenging the validity of the EPO index. Am J Kidney Dis. 2006 Jan; 47(1):166. PMID: 16377397.
      View in: PubMed
    87. Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int. 2005 Dec; 68(6):2794-800. PMID: 16316355.
      View in: PubMed
    88. Kaysen GA, Zhu F, Sarkar S, Heymsfield SB, Wong J, Kaitwatcharachai C, Kuhlmann MK, Levin NW. Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy. Am J Clin Nutr. 2005 Nov; 82(5):988-95. PMID: 16280429.
      View in: PubMed
    89. Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol. 2005 Nov; 57(11):1407-13. PMID: 16259772.
      View in: PubMed
    90. Kaysen GA. Diabetes, a cause of progressive sarcopenia in dialysis patients? Kidney Int. 2005 Nov; 68(5):2396-7. PMID: 16221246.
      View in: PubMed
    91. Shearer GC, Newman JW, Hammock BD, Kaysen GA. Graded effects of proteinuria on HDL structure in nephrotic rats. J Am Soc Nephrol. 2005 May; 16(5):1309-19. PMID: 15788471; PMCID: PMC1456011.
    92. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant. 2005 Jun; 20(6):1180-6. PMID: 15769823.
      View in: PubMed
    93. Sarkar SR, Kuhlmann MK, Khilnani R, Zhu F, Heymsfield SB, Kaysen GA, Levin NW. Assessment of body composition in long-term hemodialysis patients: rationale and methodology. J Ren Nutr. 2005 Jan; 15(1):152-8. PMID: 15648026.
      View in: PubMed
    94. Kaysen GA. Effects of inflammation on plasma composition and endothelial structure and function. J Ren Nutr. 2005 Jan; 15(1):94-8. PMID: 15648015.
      View in: PubMed
    95. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec; 17(6):432-7. PMID: 15660573.
      View in: PubMed
    96. Kaysen GA. Inflammation: cause of vascular disease and malnutrition in dialysis patients. Semin Nephrol. 2004 Sep; 24(5):431-6. PMID: 15490405.
      View in: PubMed
    97. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004 Aug; 80(2):324-32. PMID: 15277152.
      View in: PubMed
    98. Mehrotra R, Supasyndh O, Berman N, Kaysen G, Hurst L, Leonardi M, Das D, Kopple JD. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake. J Ren Nutr. 2004 Jul; 14(3):134-42. PMID: 15232791.
      View in: PubMed
    99. Kaysen GA, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004 Apr; 65(4):1408-15. PMID: 15086482.
      View in: PubMed
    100. Kaysen GA, Müller HG, Young BS, Leng X, Chertow GM. The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. J Ren Nutr. 2004 Apr; 14(2):72-81. PMID: 15060871.
      View in: PubMed
    101. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004 Mar; 15(3):538-48. PMID: 14978155.
      View in: PubMed
    102. Shearer GC, Couser WG, Kaysen GA. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL. Kidney Int. 2004 Jan; 65(1):228-37. PMID: 14675054.
      View in: PubMed
    103. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, Levin NW, Yan G. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 2003 Dec; 42(6):1200-11. PMID: 14655192.
      View in: PubMed
    104. Kaysen GA. Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int Suppl. 2003 Nov; (87):S92-8. PMID: 14531780.
      View in: PubMed
    105. Kaysen GA, Eiserich JP. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial. 2003 Nov-Dec; 16(6):438-46. PMID: 14629602.
      View in: PubMed
    106. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin N. Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis. Semin Dial. 2003 Nov-Dec; 16(6):474-6. PMID: 14629609.
      View in: PubMed
    107. Prinsen BH, Rabelink TJ, Beutler JJ, Kaysen GA, De Boer J, Boer WH, Hagen EC, Berger R, De Sain-Van Der Velden MG. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 2003 Oct; 64(4):1495-504. PMID: 12969171.
      View in: PubMed
    108. Rahmati MA, Rahmati S, Hoenich N, Ronco C, Kaysen GA, Levin R, Levin NW. On-line clearance: a useful tool for monitoring the effectiveness of the reuse procedure. ASAIO J. 2003 Sep-Oct; 49(5):543-6. PMID: 14524561.
      View in: PubMed
    109. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003 Jul; 14(7):1863-70. PMID: 12819247.
      View in: PubMed
    110. Handelman GJ, Rosales LM, Barbato D, Luscher J, Adhikarla R, Nicolosi RJ, Finkelstein FO, Ronco C, Kaysen GA, Hoenich NA, Levin NW. Breath ethane in dialysis patients and control subjects. Free Radic Biol Med. 2003 Jul 01; 35(1):17-23. PMID: 12826252.
      View in: PubMed
    111. Zhu F, Hoenich NA, Kaysen G, Ronco C, Schneditz D, Murphy L, Santacroce S, Pangilinan A, Gotch F, Levin NW. Measurement of intraperitoneal volume by segmental bioimpedance analysis during peritoneal dialysis. Am J Kidney Dis. 2003 Jul; 42(1):167-72. PMID: 12830469.
      View in: PubMed
    112. Kaysen GA, Levin NW. Why measure serum albumin levels? Adv Ren Replace Ther. 2003 Jul; 10(3):228-31. PMID: 14708078.
      View in: PubMed
    113. Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int Suppl. 2003 May; (84):S94-7. PMID: 12694319.
      View in: PubMed
    114. Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences. J Ren Nutr. 2003 Apr; 13(2):158-60. PMID: 12671842.
      View in: PubMed
    115. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM. Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr. 2003 Apr; 77(4):842-6. PMID: 12663281.
      View in: PubMed
    116. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin NW. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif. 2003; 21(1):51-7. PMID: 12566662.
      View in: PubMed
    117. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int. 2003 Jan; 63(1):315-22. PMID: 12472798.
      View in: PubMed
    118. Rahmati MA, Craig RG, Homel P, Kaysen GA, Levin NW. Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis. 2002 Nov; 40(5):983-9. PMID: 12407643.
      View in: PubMed
    119. Prinsen BH, Kaysen GA, Klomp LW, de Boer J, Barrett PH, Thornalley PJ, Battah S, Berger R, Rabelink TJ, de Sain-van der Velden MG. Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate. Clin Biochem. 2002 Oct; 35(7):545-53. PMID: 12493583.
      View in: PubMed
    120. Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis. 2002 Oct; 40(4):721-7. PMID: 12324906.
      View in: PubMed
    121. Schneditz D, Rosales L, Kaufman AM, Kaysen G, Levin NW. Heat accumulation with relative blood volume decrease. Am J Kidney Dis. 2002 Oct; 40(4):777-82. PMID: 12324913.
      View in: PubMed
    122. Kaysen GA, Levin NW. Why measure serum albumin levels? J Ren Nutr. 2002 Jul; 12(3):148-50. PMID: 12105811.
      View in: PubMed
    123. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002 Jun; 61(6):2240-9. PMID: 12028466.
      View in: PubMed
    124. Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif. 2002; 20(1):70-80. PMID: 11803162.
      View in: PubMed
    125. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Levin NW. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int. 2001 Dec; 60(6):2360-6. PMID: 11737611.
      View in: PubMed
    126. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int. 2001 Jul; 60(1):333-40. PMID: 11422769.
      View in: PubMed
    127. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001 Jul; 12(7):1549-57. PMID: 11423586.
      View in: PubMed
    128. Kaysen GA, Dubin JA, Müller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int. 2000 Jul; 58(1):346-52. PMID: 10886581.
      View in: PubMed
    129. Kaysen GA, de Sain-van der Velden MG. New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl. 1999 Jul; 71:S18-21. PMID: 10412729.
      View in: PubMed
    130. Kaysen GA, Webster S, Al-Bander H, Jones H, Hutchison FN. High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms. Miner Electrolyte Metab. 1998; 24(4):238-45. PMID: 9554562.
      View in: PubMed